Key Events This Week
6 Apr: Technical momentum shifts amid mixed market signals
8 Apr: Intraday high with 8.2% surge and significant gap up
9 Apr: Intraday high with 7.12% surge, sustained gains
10 Apr: Week closes at Rs.148.15 (+20.55%) outperforming Sensex

Sun Pharma Advanced Research Company Ltd is Rated Strong Sell
2026-04-09 10:10:18Sun Pharma Advanced Research Company Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 Feb 2024. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 09 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook.
Read full news article
Sun Pharma Advanced Research Company Ltd Surges 7.12% to Day's High of Rs 148 — Outperforms Sector by 8.07 Percentage Points
2026-04-09 09:45:57The Sensex declined by 0.73% on 09 Apr 2026, while Sun Pharma Advanced Research Company Ltd surged 7.12%, outperforming its Pharmaceuticals & Biotechnology sector by over 8 percentage points. This sharp intraday gain stands out as a stock-specific event amid a broadly weak market environment.
Read full news article
Sun Pharma Advanced Research Company Ltd Surges 8.2% to Day's High of Rs 138.3 — Outperforms Sector by 8.24 Percentage Points
2026-04-08 13:30:51The Sensex climbed 3.91% on 8 Apr 2026, yet Sun Pharma Advanced Research Company Ltd outpaced the broader market with an 8.2% gain, touching an intraday high of Rs 138.3. This 8.24 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a mere market tailwind.
Read full news article
Sun Pharma Advanced Research Company Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-04-06 08:01:47Sun Pharma Advanced Research Company Ltd (SPARC) has experienced a nuanced shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish indicators. Despite a recent uptick in price, the stock remains under pressure with a strong sell rating and a technical trend that has only marginally improved from bearish to mildly bearish, signalling cautious investor sentiment in the Pharmaceuticals & Biotechnology sector.
Read full news articleSun Pharma Advanced Research Company Ltd Gains 3.02%: Key Technical Shifts and Market Sentiment Drive Weekly Moves
2026-04-04 16:02:09
Key Events This Week
30 Mar: Sharp decline amid bearish technical momentum (Rs.114.60, -5.09%)
1 Apr: Strong gap up opening and intraday recovery (Rs.120.35, +5.02%)
2 Apr: Continued gains with moderate volume (Rs.124.40, +3.37%)
3 Apr: No trading data available

Sun Pharma Advanced Research Company Ltd Faces Bearish Momentum Amid Technical Downturn
2026-03-30 08:01:57Sun Pharma Advanced Research Company Ltd (SPARC) has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent price action, combined with deteriorating technical parameters, underscores mounting challenges for investors in this small-cap pharmaceutical and biotechnology firm.
Read full news articleCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
06-Apr-2026 | Source : BSECompliance Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018
Announcement under Regulation 30 (LODR)-Change in Management
03-Apr-2026 | Source : BSEIntimation Regarding Resignation of Dr. Shravanti Bhowmik as Head of Operations Management of the Company w.e.f. April 01 2026
Clarification sought from Sun Pharma Advanced Research Company Ltd
27-Mar-2026 | Source : BSEThe Exchange has sought clarification from Sun Pharma Advanced Research Company Ltd on March 27 2026 with reference to Movement in Volume.
The reply is awaited.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
Sun Pharma Advanced Research Company Ltd has announced 5:116 rights issue, ex-date: 16 Mar 16








